Top Analyst Upgrades and Downgrades: AIG, Align Tech, Cliffs, Cyber-Ark, MannKind, Micron and More
These are the top analyst upgrades and downgrades featured by 24/7 Wall St. for Monday, October 20, 2014.
These are the top analyst upgrades and downgrades featured by 24/7 Wall St. for Monday, October 20, 2014.
A new report from Merrill Lynch highlights five biotechs that have been absolutely crushed but have outstanding potential and catalysts that can drive them much higher.
Halliburton reported better-than-expected third-quarter 2014 results before markets opened Monday morning.
IBM released its third-quarter earnings early Monday morning, an unusual date and time for the IT services giant.
Two announcements Monday morning from Sears Holdings are intended to put some cash in the company's coffers, but in quite different ways.
The new Dodge C SRT Hellcat Charger has been priced, and it will cost at least $63,995 to own.
The October 2014 NABE Business Conditions Survey offered another sign that pessimism about the economy has spread.
The CEO of Wal-Mart de Mexico, Scot Rank, will step aside next year, according to reports. A successor has not yet been named but Walmart says it will do so soon.
U.S. ethanol producers are approaching the so-called blend wall, when the value of ethanol collapses and producers begin agitating for a higher blending limit.
As Apple's earnings approach, it is left to investors whether they believe the company's own forecast that revenue will reach a range of $39 billion.
Earlier this year, the IPO market couldn't get enough biotech. To say things have gotten tougher for those usually high-risk, high-reward plays is to put it mildly.
As we have warned over and over, GE is about to be a lot harder for analysts to understand due to its disposition of consumer finance, appliances sale and acquisitions in the hopper.
24/7 Wall St. has tracked nine stocks under $10 with big upside in which analysts recently have made key calls.
With the market very close to a full correction this past week, it should come as very little surprise that most insiders looking to sell stock chose to wait.
Nothing like the biggest market sell-off in years to get insiders' taste buds warmed up to do some buying.